NEXT
Sign in to follow

Corporate Counsel

FDA Plan for Reviewing AI-Enabled Medical Devices Isn't Quite Computing

"I think the FDA is struggling to get its arms around how to regulate it," said Kyle Faget, a partner at Foley & Lardner. "We're really in the nascent stage with AI."
5 minute read

New York Law Journal

Ready to Meet the Moment: Data Privacy and Cybersecurity Concerns Echo Throughout Biotech and Synthetic Biology

A discussion of synthetic biology and its intersection with privacy/cybersecurity laws.
10 minute read

The Recorder

Mayo Clinic, Lifepoint Claim Drugmakers Conspired to Delay Generic Competition for Chemo Drug

This suit was surfaced by Law.com Radar. Read the complaint here.
1 minute read

Daily Report Online

Why Northern District of Georgia Case Terminations Soared in 2022

What federal data tells us about trends in Georgia's district courts.
4 minute read

The Recorder

A Light at the End of the Tunnel: Rebounding Biotech Transactions Provide Hope for Life Sciences Companies

The broader biotechnology equity capital markets have rebounded from their more recent lows in June 2022, according to Sidley Austin's Frank Rahmani, Istvan Hajdu and Carlton Fleming.
7 minute read

Corporate Counsel

AI Startup Dismisses GC Amid Cash Crunch Just 1 Year After Going Public

Michael Will, who gave up his in-house job at Thrivent Financial in 2019 to help launch the business, posted on LinkedIn this week that he is looking for work.
3 minute read

Corporate Counsel

Life Sciences Startup That Ran Aground Entices New Legal Chief With Huge Equity Grant

Fresh from helping sell her last company for $2.9 billion, Heidy Abreu King-Jones will try to engineer a turnaround at Aeglea BioTherapeutics.
3 minute read

The Legal Intelligencer

Duane Morris Lands Longtime Fox Rothschild Corporate Leader

Michael Harrington spent 26 years at Fox Rothschild and roughly a dozen as chair of its corporate department.
4 minute read

Litigation Daily

Litigators of the Week: Cravath and Cooley Clear a Path for Amgen's $27.8B Acquisition of Horizon Therapeutics

The FTC and six state attorneys general dropped their challenge to the merger just 10 days after litigators at Cravath, Swaine & Moore and Cooley, repping Amgen and Horizon respectively, filed opposition briefs pushing back against the agency's preliminary injunction bid.
11 minute read

Corporate Counsel

Ex-Pfizer Legal Exec Joins AI-Powered Diagnostics Firm as First General Counsel

Louisa Daniels is taking the legal reins of Ceribell, which has raised $220 million to fund its quest to revolutionize seizure management and improve the detection of neurological conditions.
2 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now

  • White Collar Investigation Practice: Global Expertise in Complex Investigations

    Brought to you by HaystackID

    Download Now

  • Criminal Division's Evaluation of Corporate Compliance Programs: September 2024 Updates Review

    Brought to you by NAVEX Global

    Download Now